Nuwellis (NUWE) EBITDA Margin (2013 - 2026)
Nuwellis (NUWE) posted EBITDA Margin of -159.07% for Q2 2026, up 6.50 percentage points from -165.57% a year earlier and up 29.45 percentage points from the prior quarter.
Powered by 
Analysis
Nuwellis (NUWE) EBITDA Margin (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Nuwellis was -141.18%, down 25.74 percentage points year-over-year; for FY2025, it was -131.87%, down 9.70 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +91.91 percentage points (FY2020 to FY2025).
- In prior years, Nuwellis' EBITDA Margin was -122.17% in FY2024 (+72.64 pp), -194.81% in FY2023 (+1.83 pp), -196.64% in FY2022 (+43.71 pp) and -240.35% in FY2021 (-16.56 pp).
- Quarterly EBITDA Margin has run from a low of -315.72% in Q1 2023 to a high of -61.51% in Q3 2024 over five years.
- On a year-over-year basis, EBITDA Margin increased in four of the last eight quarters, with an average year-over-year change of +6.45 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2024, with a gain of 135.70 percentage points; the weakest was Q1 2023, with a drop of 91.89 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -188.51% (Q1 2026), -99.38% (Q4 2025) and -119.71% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 258.37 Bn | 237.40 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 175.14 Bn | 145.57 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 166.00 Bn | 149.80 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 152.73 Bn | 132.16 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 119.76 Bn | 85.01 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 115.60 Bn | 101.71 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 65.75 Bn | 60.52 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 54.00 Bn | 51.15 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 51.04 Bn | 35.05 Bn | 1.35 Bn | 31.93% |
| 10 | Nuwellis | 94,228.24 | -10.09 Mn | 1.50 Mn | 149.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149.57% |
| Mar 31, 2026 | -188.51% |
| Dec 31, 2025 | -99.38% |
| Sep 30, 2025 | -119.71% |
| Jun 30, 2025 | 446.20% |
| Mar 31, 2025 | -156.88% |
| Dec 31, 2024 | -99.22% |
| Sep 30, 2024 | -61.51% |
| Jun 30, 2024 | 153.24% |
| Mar 31, 2024 | -251.64% |
| Dec 31, 2023 | -0.04% |
| Sep 30, 2023 | -127.69% |
| Jun 30, 2023 | -238.02% |
| Mar 31, 2023 | -315.72% |
| Dec 31, 2022 | -190.81% |
| Sep 30, 2022 | -185.23% |
| Jun 30, 2022 | -189.79% |
| Mar 31, 2022 | -223.83% |
| Dec 31, 2021 | -257.37% |
| Sep 30, 2021 | -276.52% |
API Access
Nuwellis EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NUWE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NUWE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NUWE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();